$Alibaba(BABA)$ after going through the webcast, judging from available info without analyzing further the statements, this quarter is a confirmation that Baba is no longer growing it's most profitable core segment that has been the growth + cash cow. Digital commerce supposedly grew ~16% & Baba grew 1.4% (GMV not reported) while JD grew 5.1%. Baba will grow & fall together with it's merchants however it seems like merchants were undercut by PDD & Shared with JD Kuaishou & Bytedance. Moving forward, Baba will have to depend on growth from yet to be profitable business, eg. AIDC, CLOUD AI. however both business is an ant compare to their core e-commerce rev & profit margins. Also not profitable yet. Unless they d
$CHINA EDU GROUP(00839)$ Today's NDRC Press briefing underwhelmed international investors however, one thing they overlooked especially for domestic education sector is the lowering of loan rates for student; coupled with Xi's calls to boost domestic education & NDRC acknowledgement of a structural mismatch in the job market & talent; would boost further student enrollment for years to come especially for courses related to the so-called new productive forces industries. 🥂
$BABA-W(09988)$ Thoughts on NDRC Press Briefing: Market seems to be disappointed with the plans announced on RMB100B 💰 to local government for fiscal spending + balance RMB290B for project construction. Indeed for a USD 17.8Trillion economy, even along with PBOC announcement two weeks ago which totalled RMB 1.45 Trillion excluding adding asset swap program for brokerage & insurance comp etc. is less than 1% of GDP. However, I believed market overlooked minute details that was announced by regulators : 1) Issuance of $$ vouchers to low income group & cash voucher to support milk consumption trend - big change in Chinese gov approach which signalled they are aware of the deflation trend... Which comes to
$Coursera, Inc.(COUR)$ Food for thoughts 🤔; Both Cour & Udemy is trying to catch the corporate employee reskilling trend towards incorporation of AI into their daily routine & improve productivity. Both pursue a different path : 1) Cour : due to the pedigree of it's founder Andrew Ng, AI legend, they've provided a framework for corporate to structure their reskilling program. CEO Jeff said "corporates today are figuring out how they want to go Abt it." In recent webcast. 2) Ude : During a recent quarterly webcast, Greg (CEO) shares that, "we're in deep discussion with C'suites to co-create a corporate AI reskilling program that suit individual company needs". In your opinion, who'll get the largest pie of the massive corp
$HENLIUS(02696)$ #Privatisation Increasingly, this issue's take private bid by it's parent company, Fosun looks unfavorable to be voted through by it's shareholders due to a sudden index wide upwards revaluation. Coupled with a turnaround in earnings in recent quarter & the delay in getting necessary approvals from gov institution, it reduced likelihood & certainty of it going through.
$BABA-W(09988)$ Something worth noting here on HK common vs US ADR's. Base on calculation, for the same price per share, HK commons typically valued at a +2.8698% premium compare to US ADR's. You might think if that's the case, why buy in HK? The reason, massive 30% withholding tax on dividends for foreign person in the US. This law greatly tilt the favor towards HK common. Now looking at it, it seems cheaper already to purchase HK common. Happy weekend 😁 #ADRvsHK
$Alibaba(BABA)$ This analysis tells us that : "Management can't promise you what price the market is going to price them at tomorrow; however what it can do for you is taking care of your interest by sharing more of their earnings & always keeping you in mind."
@Max87:$Alibaba(BABA)$ Base on this Share Repurchase Update (Oct 2nd), it's pretty clear that management has repurchased 353 mln ADRs (for a whoppin...USD 27.6Billion!!?) corresponds to 13.66% outstanding shares on a non-dilutive count since Dec'22 quarter which coincides with 2 years duration since start of share repurchase program. Simple calculation would tell you that, your stake in the company would've grown in aggregate 15.82% over the past 2 years. Taking the USD 4B in dividends issued this year, total shareholder returns would total USD31.6B. If you held the shares on June 13th at closing price USD75.68/share, a USD1.66/share dividend equates to 2.19%. Therefore, Baba has returned 18.01% to her loyal shareholder over the pas
$Alibaba(BABA)$ Base on this Share Repurchase Update (Oct 2nd), it's pretty clear that management has repurchased 353 mln ADRs (for a whoppin...USD 27.6Billion!!?) corresponds to 13.66% outstanding shares on a non-dilutive count since Dec'22 quarter which coincides with 2 years duration since start of share repurchase program. Simple calculation would tell you that, your stake in the company would've grown in aggregate 15.82% over the past 2 years. Taking the USD 4B in dividends issued this year, total shareholder returns would total USD31.6B. If you held the shares on June 13th at closing price USD75.68/share, a USD1.66/share dividend equates to 2.19%. Therefore, Baba has returned 18.01% to her loyal shareholder over the pas
$Alibaba(BABA)$ Despite the recent massive rally, $BABA remains incredibly cheap… 9.17% NTM FCF yield & >USD$68B in cash/ cash equivalent nett of debt. Management'll likely continue to delever/recapitalize via divestment of non-core assets. With animal spirits back, they can now look at spinning off non-core BU as well... In aggregate, it should revalue the entire issue up several multiples inorganic/organically. Cheers 🥂
$JBM HEALTHCARE(02161)$ Warren once said "that buy companies that you won't mind owning if NYSE/NASDAQ closed down for a year". To me, its' JBM Healthcare. On the surface, its' an unknown newly floated issue. However, underneath, it represents a powerpack of legacy trusted chinese healthcare brands that has went through thick & thin with chinese people. Brand value resides in consumer's trust in them & on this scale, JBM's brands is of the highest quality. Revisiting Warren's quote at the beginning of this write up, JBM Healthcare has used its cashflow surpluses to eliminate debt (*yes, its a zero debt company); while returning shareholder value via a stock buyback program that ended up purchasing 10% of outstanding shares &
$GHY Culture(XJB.SI)$ With improving liquidity conditions in China, increased consumption will accelerate demand for film production & concerts in China. Indirectly, increase demands for it's services & improving business outlook as GHY pays off debt it incurs during covid lockdowns. [Miser] [Miser] [Miser]
$CHINA EDU GROUP(00839)$ with substantial financing denominated in USD, fed interest rate lowering would be a major driver to it's bottom line. business like universities & vocational schools has traditionally wins favor from the central gov. A combination of long term revenue visibility & lowering financing cost will allow company to repair it's balance sheet significantly & return value to investor via high dividends.